Search - tctmd.com

Displaying 261 - 280 of 1039

Sort: Relevancy | Date

News Conference News ACC 2018

PFO Closure Guided by High-Risk Features on Echo Shows Benefit in DEFENSE-PFO

Shelley Wood

March 15, 2018

News Conference News ACC 2018

Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial

Yael L. Maxwell

March 12, 2018

Presentation CHIP at ACC 2018

Update on PCI for LMCA and Multivessel Disease

Presenter: Gregg W. Stone

March 09, 2018

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

Presentation JIM 2018

Overview of New Generation Drug-Eluting Stents

Presenter: Gregg W. Stone

February 22, 2018

News Daily News

Meta-analysis Supports Benefits of Short-term DAPT Among Elderly Patients

Yael L. Maxwell

February 20, 2018

Presentation CTO 2018

Decision CTO, EURO CTO, OPEN CTO

Presenter: Gregg W. Stone, Ajay J. Kirtane

February 16, 2018

News Daily News

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

Michael O'Riordan

February 12, 2018

News Daily News

Compliance With Preventive Drugs After CABG, PCI Found Lacking in Clinical Trials

Todd Neale

February 06, 2018

STEMI Patients With Multivessel Disease Best Served by a Single Procedure: Meta-analysis

News Daily News

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

Caitlin E. Cox

December 15, 2017

News Daily News

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Michael O'Riordan

December 14, 2017

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

Presentation TCT 2017

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, William F. Fearon

November 02, 2017

Presentation TCT 2017

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Rasha Al-Lamee

November 02, 2017

Presentation TCT 2017

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Gregg W. Stone

November 01, 2017

Presentation TCT 2017

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Presenter: Gregg W. Stone, Peter H. Stone, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Presenter: Gregg W. Stone, Peter H. Stone, Evan A. Stein

November 01, 2017

Presentation TCT 2017

REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS

Presenter: Robert A. Harrington, Gregg W. Stone, Harry Suryapranata

November 01, 2017

Presentation TCT 2017

DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI

Presenter: Robert A. Harrington, Gregg W. Stone, Elvin Kedhi

November 01, 2017

Presentation TCT 2017

SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years

Presenter: Robert A. Harrington, Gregg W. Stone, Olivier Varenne

November 01, 2017

Advertisement

PFO Closure Guided by High-Risk Features on Echo Shows Benefit in DEFENSE-PFO

Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial

Update on PCI for LMCA and Multivessel Disease

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Overview of New Generation Drug-Eluting Stents

Meta-analysis Supports Benefits of Short-term DAPT Among Elderly Patients

Decision CTO, EURO CTO, OPEN CTO

One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL

Compliance With Preventive Drugs After CABG, PCI Found Lacking in Clinical Trials

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS

DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI

SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content